chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching from waist up to shoulders on his chest, stomach and sides; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching from waist up to shoulders on his chest, stomach and sides) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, LISINOPRIL, THYROID (ARMOUR THYROID), VITAMIN C [ASCORBIC ACID] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PRURITUS (itching from waist up to shoulders on his chest, stomach and sides). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching from waist up to shoulders on his chest, stomach and sides) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Arm hurt; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Eczema and Anaphylactic reaction (anaphylactic experiences). Concurrent medical conditions included Rheumatoid arthritis and Allergy. Concomitant products included ADALIMUMAB (HUMIRA) and EPINEPHRINE (EPIPEN) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt) and HEADACHE (Headache). On 01-Feb-2021, HEADACHE (Headache) had resolved. At the time of the report, VACCINATION SITE PAIN (Arm hurt) outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-044581 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Additional information received on 22/Jul/2021:Does not contains ant new information
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Breast tenderness, Feeling hot, Headache, Insomnia
Clinical narrative: little bit hurt, painful; headache; couldn't sleep well; left breast swollen; left breast tenderness; was very hot and warm.; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (left breast swollen), BREAST TENDERNESS (left breast tenderness), FEELING HOT (was very hot and warm.), PAIN (little bit hurt, painful) and INSOMNIA (couldn't sleep well) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced BREAST SWELLING (left breast swollen), BREAST TENDERNESS (left breast tenderness), FEELING HOT (was very hot and warm.) and INSOMNIA (couldn't sleep well). On 15-Mar-2021, the patient experienced PAIN (little bit hurt, painful) and HEADACHE (headache). At the time of the report, BREAST SWELLING (left breast swollen), BREAST TENDERNESS (left breast tenderness), FEELING HOT (was very hot and warm.), PAIN (little bit hurt, painful), INSOMNIA (couldn't sleep well) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. No concomitant medication was reported
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: little bit hurt, painful; headache; couldn't sleep well; left breast swollen; left breast tenderness; was very hot and warm.; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (left breast swollen), BREAST TENDERNESS (left breast tenderness), FEELING HOT (was very hot and warm.), PAIN (little bit hurt, painful) and INSOMNIA (couldn't sleep well) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced BREAST SWELLING (left breast swollen), BREAST TENDERNESS (left breast tenderness), FEELING HOT (was very hot and warm.) and INSOMNIA (couldn't sleep well). On 15-Mar-2021, the patient experienced PAIN (little bit hurt, painful) and HEADACHE (headache). At the time of the report, BREAST SWELLING (left breast swollen), BREAST TENDERNESS (left breast tenderness), FEELING HOT (was very hot and warm.), PAIN (little bit hurt, painful), INSOMNIA (couldn't sleep well) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. No concomitant medication was reported
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and INFLUENZA LIKE ILLNESS (flu-like symptoms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator. Patient took Benadryl and Zyrtec for some days and she got better.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Injection site induration, Pruritus
Clinical narrative: spread everyday, it spread around her arm; itchy; around the shot started to get hard; around the shot started to get red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (spread everyday, it spread around her arm), PRURITUS (itchy), INJECTION SITE INDURATION (around the shot started to get hard) and INJECTION SITE ERYTHEMA (around the shot started to get red) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 14M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (spread everyday, it spread around her arm), PRURITUS (itchy), INJECTION SITE INDURATION (around the shot started to get hard) and INJECTION SITE ERYTHEMA (around the shot started to get red). At the time of the report, ERYTHEMA (spread everyday, it spread around her arm), PRURITUS (itchy), INJECTION SITE INDURATION (around the shot started to get hard) and INJECTION SITE ERYTHEMA (around the shot started to get red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disturbance in attention, Fatigue, Malaise, Pain in extremity
Clinical narrative: Couldn't focus that well; Arm is a little tender; Wasn't feeling well; Feverish; Tired; Chils; This spontaneous case was reported by a consumer and describes the occurrence of DISTURBANCE IN ATTENTION (Couldn't focus that well), PAIN IN EXTREMITY (Arm is a little tender), MALAISE (Wasn't feeling well), PYREXIA (Feverish) and FATIGUE (Tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced DISTURBANCE IN ATTENTION (Couldn't focus that well), PAIN IN EXTREMITY (Arm is a little tender), MALAISE (Wasn't feeling well), PYREXIA (Feverish), FATIGUE (Tired) and CHILLS (Chils). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) on 14-Mar-2021 for Pain in arm, at an unspecified dose and frequency. On 15-Mar-2021, DISTURBANCE IN ATTENTION (Couldn't focus that well), MALAISE (Wasn't feeling well), PYREXIA (Feverish), FATIGUE (Tired) and CHILLS (Chils) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is a little tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Couldn't focus that well; Arm is a little tender; Wasn't feeling well; Feverish; Tired; Chils; This spontaneous case was reported by a consumer and describes the occurrence of DISTURBANCE IN ATTENTION (Couldn't focus that well), PAIN IN EXTREMITY (Arm is a little tender), MALAISE (Wasn't feeling well), PYREXIA (Feverish) and FATIGUE (Tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced DISTURBANCE IN ATTENTION (Couldn't focus that well), PAIN IN EXTREMITY (Arm is a little tender), MALAISE (Wasn't feeling well), PYREXIA (Feverish), FATIGUE (Tired) and CHILLS (Chils). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) on 14-Mar-2021 for Pain in arm, at an unspecified dose and frequency. On 15-Mar-2021, DISTURBANCE IN ATTENTION (Couldn't focus that well), MALAISE (Wasn't feeling well), PYREXIA (Feverish), FATIGUE (Tired) and CHILLS (Chils) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is a little tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Pain in extremity
Clinical narrative: Swollen Lymph Nodes; Arm Soreness; Slight Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen Lymph Nodes), PAIN IN EXTREMITY (Arm Soreness) and FATIGUE (Slight Fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history reported by reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), AZILSARTAN KAMEDOXOMIL (EDARBI) and CHLORTHALIDONE for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced LYMPHADENOPATHY (Swollen Lymph Nodes), PAIN IN EXTREMITY (Arm Soreness) and FATIGUE (Slight Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 15-Feb-2021, LYMPHADENOPATHY (Swollen Lymph Nodes) and PAIN IN EXTREMITY (Arm Soreness) had resolved. At the time of the report, FATIGUE (Slight Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-053474 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal
Clinical narrative: she has had more diarrhea; felt terrible; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt terrible) and DIARRHOEA (she has had more diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome.   On 13-Mar-2021 at 5:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced FEELING ABNORMAL (felt terrible). On 15-Mar-2021, the patient experienced DIARRHOEA (she has had more diarrhea). At the time of the report, FEELING ABNORMAL (felt terrible) and DIARRHOEA (she has had more diarrhea) outcome was unknown.            No concomitant medications were provided by the reporter.  Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Excruishiating pain in the right arm, center deltoid from the elbow to the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Excruishiating pain in the right arm, center deltoid from the elbow to the shoulder) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SIMVASTATIN, ARIPIPRAZOLE (ABILIFY), SERTRALINE and METFORMIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Excruishiating pain in the right arm, center deltoid from the elbow to the shoulder). The patient was treated with HYDROMORPHONE at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Excruishiating pain in the right arm, center deltoid from the elbow to the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  On 05-Mar-2021, the patient received their first dose of vaccine and experienced excruciating pain in the right arm and center deltoid from the elbow to the shoulder.  Treatment information provided by the reporter also included heating pad.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: allergic reaction; broke into hives around the body; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) and URTICARIA (broke into hives around the body) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced HYPERSENSITIVITY (allergic reaction) and URTICARIA (broke into hives around the body). At the time of the report, HYPERSENSITIVITY (allergic reaction) and URTICARIA (broke into hives around the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No information on treatment medication at the time of first dose was reported.   This case was linked to MOD-2021-032898 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms come and go; flu-like symptoms 11 days after receiving 1st dose; flu-like symptoms 5 days after receiving 1st dose; flu-like symptoms 2 days after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms 2 days after receiving 1st dose), INFLUENZA LIKE ILLNESS (flu-like symptoms come and go), INFLUENZA LIKE ILLNESS (flu-like symptoms 5 days after receiving 1st dose) and INFLUENZA LIKE ILLNESS (flu-like symptoms 11 days after receiving 1st dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms 2 days after receiving 1st dose). On 08-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms 5 days after receiving 1st dose). On 14-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms 11 days after receiving 1st dose). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms come and go). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms 2 days after receiving 1st dose), INFLUENZA LIKE ILLNESS (flu-like symptoms 5 days after receiving 1st dose) and INFLUENZA LIKE ILLNESS (flu-like symptoms 11 days after receiving 1st dose) had resolved and INFLUENZA LIKE ILLNESS (flu-like symptoms come and go) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Rash
Clinical narrative: Rash on the neck /chest/ back/ belly; Fever; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever), HEADACHE (Headache) and RASH (Rash on the neck /chest/ back/ belly) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). On 07-Mar-2021, the patient experienced RASH (Rash on the neck /chest/ back/ belly). At the time of the report, PYREXIA (Fever), HEADACHE (Headache) and RASH (Rash on the neck /chest/ back/ belly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Patient went to urgent care and received unspecified steroid shot and pills as treatment for the symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Electric shock sensation, Erythema, Fatigue, Headache
Clinical narrative: headache; muscle pain; joint pain; fatigue; blister/pocket of infection developed on thumb; feels like electric shock in fingers and hand; Swelling in the left hand/Left thumb swelling; Thumb is fire red; pain in hand/thumb; numbness in fingers; can't bend fingers; A spontaneous report was received from a consumer concerning about a 71 years old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced feels like electric shock in fingers and hand (electric shock sensation), swelling in the left hand/left thumb swelling (peripheral swelling), thumb is fire red (erythema), pain in hand/thumb (pain in extremity), numbness in fingers (hypoaesthesia), can't bend fingers (musculoskeletal stiffness), blister/pocket of infection developed on thumb (infection localized), headache, muscle pain (myalgia) and joint pain (arthralgia).  The patient's medical history was not reported.  Concomitant medications included pain medications, acid reflux medication, blood pressure medication, and aspirin.    On 05 Feb 2021, prior to the onset of the events, the patient received their first planned doses of mRNA-1273 (Batch number: 013M20A) intramuscularly in left arm for the prophylaxis of COVID-19 infection.  On 10 Feb 2021, five days following the first vaccination, the patient experienced swelling in the left hand, left thumb swelling, thumb is fire red, swelling, painful, numbness in fingers, feels like electric shock in fingers and hand and cannot bend fingers. On 16 Feb 2021, patient saw physician and received antibiotics for seven day treatment due to a blister/pocket of infection that developed on thumb. Patient's hand and thumb remained serious at the time of the report and the pinky finger was twice the usual size. The patient reported generalized headache (on and off), muscle pain, joint pain, and fatigue.   Treatment information included unspecified antibiotics.  There was no change planned to the dosing schedule of mRNA-1273 in response to the events.  The outcomes of all the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Localised infection, Musculoskeletal stiffness, Myalgia, Pain in extremity
Clinical narrative: headache; muscle pain; joint pain; fatigue; blister/pocket of infection developed on thumb; feels like electric shock in fingers and hand; Swelling in the left hand/Left thumb swelling; Thumb is fire red; pain in hand/thumb; numbness in fingers; can't bend fingers; A spontaneous report was received from a consumer concerning about a 71 years old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced feels like electric shock in fingers and hand (electric shock sensation), swelling in the left hand/left thumb swelling (peripheral swelling), thumb is fire red (erythema), pain in hand/thumb (pain in extremity), numbness in fingers (hypoaesthesia), can't bend fingers (musculoskeletal stiffness), blister/pocket of infection developed on thumb (infection localized), headache, muscle pain (myalgia) and joint pain (arthralgia).  The patient's medical history was not reported.  Concomitant medications included pain medications, acid reflux medication, blood pressure medication, and aspirin.    On 05 Feb 2021, prior to the onset of the events, the patient received their first planned doses of mRNA-1273 (Batch number: 013M20A) intramuscularly in left arm for the prophylaxis of COVID-19 infection.  On 10 Feb 2021, five days following the first vaccination, the patient experienced swelling in the left hand, left thumb swelling, thumb is fire red, swelling, painful, numbness in fingers, feels like electric shock in fingers and hand and cannot bend fingers. On 16 Feb 2021, patient saw physician and received antibiotics for seven day treatment due to a blister/pocket of infection that developed on thumb. Patient's hand and thumb remained serious at the time of the report and the pinky finger was twice the usual size. The patient reported generalized headache (on and off), muscle pain, joint pain, and fatigue.   Treatment information included unspecified antibiotics.  There was no change planned to the dosing schedule of mRNA-1273 in response to the events.  The outcomes of all the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: headache; muscle pain; joint pain; fatigue; blister/pocket of infection developed on thumb; feels like electric shock in fingers and hand; Swelling in the left hand/Left thumb swelling; Thumb is fire red; pain in hand/thumb; numbness in fingers; can't bend fingers; A spontaneous report was received from a consumer concerning about a 71 years old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced feels like electric shock in fingers and hand (electric shock sensation), swelling in the left hand/left thumb swelling (peripheral swelling), thumb is fire red (erythema), pain in hand/thumb (pain in extremity), numbness in fingers (hypoaesthesia), can't bend fingers (musculoskeletal stiffness), blister/pocket of infection developed on thumb (infection localized), headache, muscle pain (myalgia) and joint pain (arthralgia).  The patient's medical history was not reported.  Concomitant medications included pain medications, acid reflux medication, blood pressure medication, and aspirin.    On 05 Feb 2021, prior to the onset of the events, the patient received their first planned doses of mRNA-1273 (Batch number: 013M20A) intramuscularly in left arm for the prophylaxis of COVID-19 infection.  On 10 Feb 2021, five days following the first vaccination, the patient experienced swelling in the left hand, left thumb swelling, thumb is fire red, swelling, painful, numbness in fingers, feels like electric shock in fingers and hand and cannot bend fingers. On 16 Feb 2021, patient saw physician and received antibiotics for seven day treatment due to a blister/pocket of infection that developed on thumb. Patient's hand and thumb remained serious at the time of the report and the pinky finger was twice the usual size. The patient reported generalized headache (on and off), muscle pain, joint pain, and fatigue.   Treatment information included unspecified antibiotics.  There was no change planned to the dosing schedule of mRNA-1273 in response to the events.  The outcomes of all the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: Severe Vertigo; Tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Severe Vertigo) and TINNITUS (Tinnitus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Severe Vertigo) and TINNITUS (Tinnitus). At the time of the report, VERTIGO (Severe Vertigo) and TINNITUS (Tinnitus) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up received on 14-MAR-2021 and reporter Information Updated.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: spreading; rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) and VACCINATION SITE RASH (spreading) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was reported.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced RASH (rash). On 14-Mar-2021, the patient experienced VACCINATION SITE RASH (spreading). The patient was treated with PREDNISONE at an unspecified dose and frequency; FAMOTIDINE (PEPCID AC) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (rash) and VACCINATION SITE RASH (spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fall
Clinical narrative: Fell down; hurt his knees; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell down) and ARTHRALGIA (hurt his knees) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced FALL (Fell down) and ARTHRALGIA (hurt his knees). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of taking for past 2 days. At the time of the report, FALL (Fell down) and ARTHRALGIA (hurt his knees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Nodule, Product administered at inappropriate site
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), NODULE (lump) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Possible wrong site of injection: 2nd vaccine was given 3 inches below 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included ACETAMINOPHEN for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced ERYTHEMA (redness) and NODULE (lump). On 14-Mar-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Possible wrong site of injection: 2nd vaccine was given 3 inches below 1st dose). At the time of the report, ERYTHEMA (redness) and NODULE (lump) outcome was unknown and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Possible wrong site of injection: 2nd vaccine was given 3 inches below 1st dose) had resolved. No treatment medications were reported. This case was linked to MOD-2021-044712.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeding; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nose bleeding) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (Nose bleeding). At the time of the report, EPISTAXIS (Nose bleeding) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.   Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Pain in extremity, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Itchy around injection site; redness around injection site; swelling around injection site; sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), INJECTION SITE PRURITUS (Itchy around injection site), VACCINATION SITE ERYTHEMA (redness around injection site) and VACCINATION SITE SWELLING (swelling around injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), LISINOPRIL, CHLORTHALIDONE and POTASSIUM CHLORIDE for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 12-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Itchy around injection site), VACCINATION SITE ERYTHEMA (redness around injection site) and VACCINATION SITE SWELLING (swelling around injection site). The patient was treated with CORTISONE at an unspecified dose and frequency. On 06-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, INJECTION SITE PRURITUS (Itchy around injection site), VACCINATION SITE ERYTHEMA (redness around injection site) and VACCINATION SITE SWELLING (swelling around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included ice pack application.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Diarrhoea, Pyrexia
Clinical narrative: weak; chills; fever; diarrhea; cough; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), DIARRHOEA (diarrhea), COUGH (cough) and ASTHENIA (weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included No adverse event.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever), DIARRHOEA (diarrhea) and COUGH (cough). On 15-Mar-2021, the patient experienced ASTHENIA (weak). On 15-Mar-2021, CHILLS (chills), PYREXIA (fever) and DIARRHOEA (diarrhea) had resolved. At the time of the report, COUGH (cough) and ASTHENIA (weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced URTICARIA (hives). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not report concomitant medication use. The patient reported the event resolved within 36-48 hours.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Normal redness at injection site; Swollen/swelling at injection site; Arm started itching; Rash 6 inches by 3 inches across; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm started itching), RASH (Rash 6 inches by 3 inches across), VACCINATION SITE ERYTHEMA (Normal redness at injection site) and VACCINATION SITE SWELLING (Swollen/swelling at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PRURITUS (Arm started itching) and RASH (Rash 6 inches by 3 inches across). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Normal redness at injection site) and VACCINATION SITE SWELLING (Swollen/swelling at injection site). On 06-Mar-2021, PRURITUS (Arm started itching) and RASH (Rash 6 inches by 3 inches across) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Normal redness at injection site) and VACCINATION SITE SWELLING (Swollen/swelling at injection site) outcome was unknown.            No concomitant medications were reported.No treatment information was provided.Action taken with mRNA-1273 in response to the events was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea
Clinical narrative: Severe cough; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Severe cough) and RHINORRHOEA (Runny nose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced COUGH (Severe cough) and RHINORRHOEA (Runny nose). At the time of the report, COUGH (Severe cough) and RHINORRHOEA (Runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.No treatment was reported for the events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Paraesthesia oral
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling in her lips) and LIP SWELLING (lips were completely swollen) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced PARAESTHESIA ORAL (tingling in her lips) and LIP SWELLING (lips were completely swollen). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Tingling lips and Lip swelling, at an unspecified dose and frequency and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Tingling lips and Lip swelling, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA ORAL (tingling in her lips) had resolved and LIP SWELLING (lips were completely swollen) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itching; rash on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching) and VACCINATION SITE RASH (rash on the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching) and VACCINATION SITE RASH (rash on the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching) and VACCINATION SITE RASH (rash on the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.No treatment was reported for the events.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up information received on 06 May 2021.Added second dose details and updated outcome of events.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: muscle ache; chills; high fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle ache), CHILLS (chills), PYREXIA (high fever) and HEADACHE (Headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced MYALGIA (muscle ache), CHILLS (chills), PYREXIA (high fever) and HEADACHE (Headache). On 08-Mar-2021, MYALGIA (muscle ache), CHILLS (chills), PYREXIA (high fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: fatigue; high temperature; Chiils; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), PYREXIA (high temperature), CHILLS (Chiils) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced FATIGUE (fatigue), PYREXIA (high temperature), CHILLS (Chiils) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, FATIGUE (fatigue) had not resolved and PYREXIA (high temperature), CHILLS (Chiils) and HEADACHE (headache) was resolving.            No relevant concomitant medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza, Pyrexia, Vaccination site pruritus
Clinical narrative: arm itching a lot around the area; Fever; flu symptoms; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (flu symptoms), VACCINATION SITE PRURITUS (arm itching a lot around the area), PYREXIA (Fever) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (headache). On 07-Mar-2021, the patient experienced INFLUENZA (flu symptoms). 07-Mar-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (arm itching a lot around the area). On 08-Mar-2021, INFLUENZA (flu symptoms), PYREXIA (Fever) and HEADACHE (headache) had resolved. At the time of the report, VACCINATION SITE PRURITUS (arm itching a lot around the area) outcome was unknown.            Treatment included something for headache and for Itchy. Concomitant medications were not provided.Action taken with mRNA-1273 in response to the events was not applicable.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash, Vaccination site reaction
Clinical narrative: it is sensitive, not itchy; appeared a rush, it at the injection site; sore right arm at the the injection site, very mild; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (it is sensitive, not itchy), VACCINATION SITE RASH (appeared a rush, it at the injection site) and VACCINATION SITE PAIN (sore right arm at the the injection site, very mild) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included MONTELUKAST and MULTIVITAMIN & MINERAL.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore right arm at the the injection site, very mild). On 05-Feb-2021, the patient experienced VACCINATION SITE REACTION (it is sensitive, not itchy) and VACCINATION SITE RASH (appeared a rush, it at the injection site). On 05-Feb-2021, VACCINATION SITE PAIN (sore right arm at the the injection site, very mild) had resolved. At the time of the report, VACCINATION SITE REACTION (it is sensitive, not itchy) and VACCINATION SITE RASH (appeared a rush, it at the injection site) outcome was unknown.            Concomitant medication also include injection for osteoporosis. Treatment information was not provided. Action taken with mRNA -123 is not applicable.   Reporter did not allow further contact
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Decreased appetite, Headache, Pyrexia
Clinical narrative: have no appetite; was very weak; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (have no appetite), ASTHENIA (was very weak), HEADACHE (headache) and PYREXIA (fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Multiple sclerosis. Concomitant products included METFORMIN, CANAGLIFLOZIN HEMIHYDRATE, METFORMIN HYDROCHLORIDE (INVOKANA DUO) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DECREASED APPETITE (have no appetite), ASTHENIA (was very weak), HEADACHE (headache) and PYREXIA (fever). On 12-Mar-2021, DECREASED APPETITE (have no appetite), ASTHENIA (was very weak) and PYREXIA (fever) had resolved. On 14-Mar-2021, HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 100.7 (High) 100.7 degrees Fahrenheit.. On 12-Mar-2021, Body temperature: 98 (High) Rechecked next day, temperature decreased to 98 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.